Overview

Print Print page     Email Email page
Manhattan Pharmaceuticals, Inc. is a specialty healthcare product company focused on developing and commercializing innovative treatments for underserved patient populations.
Stock Information
OTCBB:MHAND
$0.02   + 0.00
Dec 30, 2011
3:35 PM ET
Quotes delayed at least 20 minutes.
Information provided by eSignal.
Manhattan Pharmaceuticals Stock Chart
3 Mo.   6 Mo.   1 Yr.

Recent Releases

Jul 21, 2011
Manhattan Pharmaceuticals, Inc. Reaches Agreement With the FDA on a Special Protocol Assessment for the Phase 3 Clinical Study of AST-726

Jul 13, 2011
Manhattan Pharmaceuticals, Inc. Announces Reverse Stock Split

View all releases »

Events & Presentations

Oct 13, 2010 at 11:00 AM ET
Precision IR Biotech, Healthcare & Pharmaceutical Virtual Conference

May 20, 2008 at 7:40 AM ET
Manhattan Pharmaceuticals to Present at Rodman & Renshaw 5th Annual Global Healthcare Conference

View all events & presentations »